APAF-1 (Apoptotic Protease Activating Factor 1) is a cytosolic protein that plays a central role in the intrinsic (mitochondrial) apoptosis pathway. It serves as the central organizing platform for caspase-9 activation following mitochondrial cytochrome c release, making it a critical regulator of programmed cell death in neurons.
| Property |
Value |
| Gene |
APAF1 |
| UniProt ID |
O14727 |
| PDB Structures |
1ZXW, 2YJD, 3O0Y |
| Molecular Weight |
~140 kDa |
| Subcellular Localization |
Cytoplasm, mitochondrial outer membrane |
| Protein Family |
Apoptosis protein family |
APAF-1 contains multiple functional domains:
- N-terminal CARD domain (caspase recruitment domain): Mediates interaction with procaspase-9
- NOD domain (nucleotide oligomerization domain): ATPase domain that undergoes conformational changes
- WD40 repeats (C-terminal): Forms a regulatory "wheel" structure that binds cytochrome c
The APAF-1 monomer can form a heptameric "apoptosome" complex when bound to cytochrome c and ATP/dATP.
In healthy neurons, APAF-1 is constitutively expressed in the cytoplasm. Its primary functions include:
- Apoptosome assembly: Upon cytochrome c release from damaged mitochondria, APAF-1 binds cytochrome c via its WD40 domain, undergoes conformational change, and oligomerizes into the apoptosome
- Caspase activation: The apoptosome recruits and activates procaspase-9, initiating the caspase cascade leading to cellular demolition
- DNA repair coordination: APAF-1 interacts with DNA repair proteins to coordinate repair attempts before committing to apoptosis
- Amyloid-beta toxicity: Aβ exposure triggers mitochondrial dysfunction and cytochrome c release, leading to APAF-1-mediated apoptosis in neurons
- Impaired clearance: Reduced ability to clear damaged neurons may contribute to pathological accumulation
- Mitochondrial dysfunction: PINK1/Parkin pathway defects lead to increased mitochondrial stress and APAF-1 activation
- Dopaminergic neuron vulnerability: The intrinsic apoptosis pathway is particularly active in dopaminergic neurons
- Mitochondrial permeability transition: Mutant SOD1 and other ALS proteins cause mitochondrial dysfunction, activating APAF-1
- Caspase activation: Elevated caspase-9 activation observed in ALS motor neurons
- Mutant huntingtin effects: mHtt disrupts mitochondrial function, increasing APAF-1 pathway activation
- Transcriptional dysregulation: APAF1 gene expression is altered in HD models
- Small molecule inhibitors: Research compounds targeting APAF-1 oligomerization
- Caspase inhibitors: Downstream blockade of the apoptosis cascade
- Neuroprotective approaches: Enhancing anti-apoptotic Bcl-2 family proteins
- Mitochondrial stabilization: Protecting mitochondria from permeabilization